Key facts
- Digital therapeutics showed a 0.54% reduction in HbA1c levels.
- The 4th AGP & DTx Summit was held in Shenzhen in May 2026.
- The summit's theme was 'Beyond Glucose.'
- SIBIONICS co-organized the summit.
The 4th AGP & DTx Summit, held in Shenzhen in May 2026, concluded with the theme 'Beyond Glucose.' Co-organized by SIBIONICS, the event gathered international experts and healthcare professionals to discuss advancements in diabetes care. A key finding presented was that digital therapeutics demonstrated a significant 0.54% reduction in HbA1c levels, indicating a shift in the approach to managing diabetes from mere monitoring towards driving active behavioral change.